APA (7th ed.) Citation

DE, R., R, K., JH, L., S, H., W, F., K, F., . . . KH, S. (2017). Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide. Leukemia & lymphoma, 58(3), 560. https://doi.org/10.1080/10428194.2016.1207763

Chicago Style (17th ed.) Citation

DE, Rollison, et al. "Subsequent Primary Malignancies Among Multiple Myeloma Patients Treated with or Without Lenalidomide." Leukemia & Lymphoma 58, no. 3 (2017): 560. https://doi.org/10.1080/10428194.2016.1207763.

MLA (9th ed.) Citation

DE, Rollison, et al. "Subsequent Primary Malignancies Among Multiple Myeloma Patients Treated with or Without Lenalidomide." Leukemia & Lymphoma, vol. 58, no. 3, 2017, p. 560, https://doi.org/10.1080/10428194.2016.1207763.